Cellectis S.A.
CLLS | NASDAQ
$1.60
+$0.09 (+5.96%)
Sep 22, 2026, 11:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 72.95M | 41.51M | 755K | 19.17M | 30.35M | 51.06M |
Cost of Revenue | 9.8M | 9.18M | 7.42M | 8.48M | 1.84M | 1.95M |
Gross Profit | 63.15M | 32.32M | -6.66M | 10.69M | 28.5M | 49.11M |
Operating Income | -33.08M | -59.55M | -97.3M | -89.67M | -103.48M | -42.31M |
Interest Income | 9.5M | 11.28M | 3.61M | 1.12M | 719K | 1.96M |
Pretax Income | -68.02M | -36.76M | -116.46M | -98.6M | -96.75M | -53.58M |
Net Income | -67.59M | -36.76M | -101.06M | -106.14M | -114.2M | -81.07M |
Selling & General & Admin | 8.6M | 8.42M | 8.12M | 8.9M | 22.88M | 22.51M |
Research & Development | 93.52M | 90.54M | 87.65M | 97.5M | 117.84M | 77.05M |
Other Expenses | -5.89M | -7.08M | -5.13M | -6.04M | -8.74M | -8.15M |
Operating Expenses | 96.23M | 91.88M | 90.64M | 100.35M | 131.98M | 91.42M |
Interest Expense | 8.11M | 7.45M | 5.31M | 3.79M | 4.37M | 3.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 2.71M | n/a |
Cost & Expenses | 106.03M | 101.06M | 98.06M | 108.84M | 133.83M | 93.37M |
Income Tax Expense | -423K | n/a | 371K | 87K | -3K | n/a |
Shares Outstanding (Basic) | 100.28M | 90.57M | 57.01M | 45.55M | 44.82M | 42.5M |
Shares Outstanding (Diluted) | 100.28M | 90.57M | 57.01M | 45.55M | 44.82M | 42.5M |
EPS (Basic) | -0.68 | -0.41 | -1.77 | -2.33 | -1.93 | -1.71 |
EPS (Diluted) | -0.68 | -0.41 | -1.77 | -2.33 | -1.93 | -1.71 |
EBITDA | -39.85M | -9.46M | -92.64M | -76.38M | -78.43M | -43.34M |
EBIT | -59.91M | -29.31M | -111.16M | -94.81M | -92.58M | -51.18M |
Depreciation & Amortization | 20.06M | 19.85M | 18.52M | 18.44M | 14.16M | 7.83M |
Add to Watchlist
Select watchlists to add or remove CLLS